These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

378 related items for PubMed ID: 17883690

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Proliferative activity (Ki-67), WT p53, Bcl-2 expression and their relationship to the tumor grade, in invasive ductal breast carcinomas.
    Kalogeraki A, Garbagnati F, Santinami M, Zoras O.
    In Vivo; 2002; 16(2):141-4. PubMed ID: 12073773
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Comparative study of P 53, Bcl-2, and C-erbB-2 expression in low-grade papillary bladder tumors].
    Ramos Soler D, Navarro Fos S, Villamón Fort R, Gil Salom M, Llombart Bosch A.
    Arch Esp Urol; 2003 Apr; 56(3):277-85. PubMed ID: 12768988
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Prognostic significance of ER, PR, Ki67, c-erbB-2, and p53 in endometrial carcinoma.
    Suthipintawong C, Wejaranayang C, Vipupinyo C.
    J Med Assoc Thai; 2008 Dec; 91(12):1779-84. PubMed ID: 19133508
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Prognostic significance of p53 gene mutations and protein overexpression in localized gastrointestinal stromal tumours.
    Ryu MH, Kang YK, Jang SJ, Kim TW, Lee H, Kim JS, Park YH, Lee SS, Ryoo BY, Chang HM, Lee JL, Yook JH, Kim BS, Lee JS.
    Histopathology; 2007 Sep; 51(3):379-89. PubMed ID: 17727479
    [Abstract] [Full Text] [Related]

  • 37. Immunohistochemical prognostic indicators of gastrointestinal carcinoid tumours.
    Kawahara M, Kammori M, Kanauchi H, Noguchi C, Kuramoto S, Kaminishi M, Endo H, Takubo K.
    Eur J Surg Oncol; 2002 Mar; 28(2):140-6. PubMed ID: 11884049
    [Abstract] [Full Text] [Related]

  • 38. [Immunomorphological characteristics and criteria for predicting gastrointestinal stromal tumors].
    Kravtsov VG, Zaĭrat'iants OV, Shirin Ch, Shakhmurov M, Shabat V, Kripshpon I, Alin A, Avinoach I, Avni J.
    Arkh Patol; 2007 Mar; 69(5):25-8. PubMed ID: 18074815
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Expression of p53 and bcl-2 proteins in acute leukemias: an immunocytochemical study.
    Klobusická M, Kusenda J, Babusíkova O.
    Neoplasma; 2001 Mar; 48(6):489-95. PubMed ID: 11949843
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.